Roberts Jessica K, Stockmann Chris, Balch Alfred, Yu Tian, Ward Robert M, Spigarelli Michael G, Sherwin Catherine M T
Division of Clinical Pharmacology, Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, UT, USA.
Paediatr Anaesth. 2015 Mar;25(3):222-30. doi: 10.1111/pan.12575. Epub 2015 Jan 9.
It is not trivial to conduct clinical trials with pediatric participants. Ethical, logistical, and financial considerations add to the complexity of pediatric studies. Optimal design theory allows investigators the opportunity to apply mathematical optimization algorithms to define how to structure their data collection to answer focused research questions. These techniques can be used to determine an optimal sample size, optimal sample times, and the number of samples required for pharmacokinetic and pharmacodynamic studies. The aim of this review is to demonstrate how to determine optimal sample size, optimal sample times, and the number of samples required from each patient by presenting specific examples using optimal design tools. Additionally, this review aims to discuss the relative usefulness of sparse vs rich data. This review is intended to educate the clinician, as well as the basic research scientist, whom plan on conducting a pharmacokinetic/pharmacodynamic clinical trial in pediatric patients.
对儿科参与者进行临床试验并非易事。伦理、后勤和财务方面的考虑增加了儿科研究的复杂性。最优设计理论使研究人员有机会应用数学优化算法来确定如何构建数据收集方式,以回答重点研究问题。这些技术可用于确定最优样本量、最优采样时间以及药代动力学和药效学研究所需的样本数量。本综述的目的是通过使用最优设计工具展示具体示例,来说明如何确定最优样本量、最优采样时间以及每位患者所需的样本数量。此外,本综述旨在讨论稀疏数据与丰富数据的相对有用性。本综述旨在教育计划对儿科患者进行药代动力学/药效学临床试验的临床医生以及基础研究科学家。